Hypertension is now usually discovered at routine examination or in patients who present with symptoms unrelated to the level of blood pressure. Investigation will rarely reveal a curable cause. Age, sex, and height of blood pressure usually decide whether medication should be started. These symptomless patients then face many years of swallowing tablets. Clearly, the ideal treatment regimen should lower blood pressure independently of posture, without inducing troublesome sideeffects, and should be simple to prescribe and take. To the prescriber simplicity means confidence in potency and a dose range that is easy to adjust. To the patient it will seem a poor bargain to have to swallow a large number of tablets several times a day for a statistical chance of a longer life, especially if the tablets are not innocuous.
How closely does beta blockade approach this ideal? POTENCY All beta blocking drugs at present available have been shown to lower blood pressure (Morgan et al., 1974; Davidson et al., 1976) . After recognising the hypotensive action of propranolol, Prichard and Gillam (1969) assessed its potency in a group of patients previously used in a trial to compare guanethidine, bethanidine, and methyldopa. They found propranolol to be of similar potency to the previously used drugs. Our own within-patient double-blind comparison of oxprenolol and methyldopa showed virtually identical pressure falls with both drugs. Thomas and coworkers (1976) also compared methyldopa, oxprenolol, and spironolactone and found no significant differences between the hypotensive effects of the three agents.
Hydrochlorothiazide 50 mg daily was compared with timolol in a double-blind within-patient trial by Chalmers and co-workers (1976) and found to be "Bristol Royal Infirmary. slightly less potent. Petrie et al. (1975) have also shown that beta blockade causes a slightly greater fall in blood pressure than a thiazide diuretic in a trial which compared atenolol with 5 mg bendrofluazide daily.
We assessed oxprenolol used alone in 40 patients and found the range of fall in mean blood pressure was 0 to 40 mmHg (average fall 20 mmHg) (Barritt and Marshall, 1977 (Galloway et al., 1976; Barritt and Marshall, 1977; Marshall et al., 1977b) .
It can now be predicted with confidence that, if a group of hypertensive patients is given propranolol or oxprenolol in a dose of 80 or 160 mg twice daily or atenolol 100 mg once daily, the average fall in mean blood pressure will be 20 mmHg and the range 0 to 40 mmHg. The result of treatment will be 821 group.bmj.com on June 20, 2017 -Published by http://heart.bmj.com/ Downloaded from evident at the first out-patient visit. Though the plasma half-lives of these drugs suggested that they would need to be given three times daily, it is clear that the effect on heart rate, and especially blood pressure, may last 24 hours or more. The evidence that atenolol is as effective when given once daily as in divided doses appears conclusive (Woolfson and Knapp, 1976; Marshall et al., 1977b) . The same may well be true of propranolol and other beta blocking drugs (Wilson et al., 1976) . Beta blockade can be used as a simple once daily regimen for hypertension, and its effect fully assessed within two weeks.
SIDE-EFFECTS
Postural hypotension is exceptional with beta blockade, as is impairment of sexual performance or mental slowing, which are the major disadvantages of other current therapy. Used carefully in selected patients, side-effects are few. Nevertheless, betablockade invariably lowers cardiac output and is, therefore, quite unsuitable for patients with left ventricular failure. Though some beta blocking agents appear to have little effect on airways resistance, it seems wise to regard a history of wheezing as a contraindication to their use. The only common and undisputed side-effect of beta blockade is the development of cold hands and feet. When the specific question is asked, over onequarter of patients taking beta blocking drugs admit to the development of cold hands and feet . Cold extremities are associated with absence of foot pulses and it is our practice to look for symptoms and signs of peripheral vascular disease, and if these are present to avoid beta blockade or use it with caution. Propranolol and atenolol commonly produce resting heart rates of 50 beats a minute. This is a good guide to the physician that the tablets have been taken, but bradycardia is not usually associated with symptoms unless the patient also has sinoatrial disease. Beta blockade is best avoided in insulindependent diabetics. Not only may the treatment mask the symptoms and signs of hypoglycaemic attacks, but may also help to induce hypoglycaemia by inhibiting hepatic gluconeogenesis.
No discussion of long-term treatment with betablockade can ignore the emergence of the practolol syndrome. All who prescribe these agents must be aware of its severity (Marshall et al., 1977a) . The use of beta blocking agents in therapeutics is an example of the oscillations in the popularity of a new drug, as described by Lawrence (1966 How does beta-blockade lower blood pressure?
It has been suggested that beta-blockade may lower blood pressure (1) by reducing both the cardiac output at rest and the increases in output induced by exercise and catecholamine activity, this adjustment leading to the resetting of cardiovascular reflexes; (2) by suppressing plasma renin activity; (3) by a central action in the brain. There are serious objections to accepting any of these three alone as explaining the mode of action.
Certainly the most obvious effect of betablockade is a slowing of the heart rate which is accompanied by a measurable fall in cardiac output. Unless the peripheral resistance rises, blood pressure must fall, and after a period of time the baroreceptors may reset at a lower level of activity and a sustained fall in resistance may result. This would lead to the idea that hypertensive patients with high levels of cardiac output might respond better than those with low cardiac output (Ulrych et al., 1968) . The resting heart rate gives some indication of the level of cardiac output. Our own analysis shows that the relation between initial heart rate, the fall of heart rate with the drug, and the fall in pressure with oxprenolol, is so variable that reduction of cardiac output alone seems unlikely to account for its hypotensive action. Not only is initial heart rate a poor guide to response to treatment (Fig.) but in addition there is little relation between the fall in heart rate that occurs with the drug and the fall in blood pressure. If a fall in cardiac output is invariable with beta blockade a fall in pressure is not.
Most beta blocking drugs have been shown to depress levels of plasma renin activity (Biihler et al., 1972) . The exception is pindolol (Weber et 1974). Thus the renin state of the patient a major part in determining the respor Biihler and co-workers, who divide tb tensive patients into high, normal, and groups, have produced evidence that the group respond well to propranolol an renin group poorly. Other workers hav confirm this. Stokes et al. (1974) As the size of blood pressure fall with all the hypoe. There tensive agents is limited, it follows that the higher 1 heart the initial blood pressure, the more likely it is that 2tion more than one agent will be required. If betablockade fails to lower blood pressure to an acceptable level, the addition of a different type of hypotensive agent can be expected to cause a further fall. The addition of a thiazide diuretic could play produces on average a further fall in mean blood ise. Indeed pressure of 13 per cent with few side-effects, at the leir hyper-cost of one extra tablet daily (Marshall et al., 1977c) . low renin The argument could be put that the rarity of high renin symptomatic side-effects with diuretics should make Id the low them the agent of first choice. In our view preference e failed to goes to beta blocking drugs in view of their slightly red plasma greater potency, their undisputed antiarrhythmic with pro-action, and the possibility that they may reduce the ssion of the incidence of myocardial infarction. A proportion of nt, but the severe hypertensives will need a third or fourth vith the fall agent. Success has been reported by adding ndolol was methyldopa (Scott et al., 1977) , hydrallazine nin activity (Wilcox and Mitchell, 1977) , or prazosin (Marshall homas and et al., 1977c) to treatment with beta-blocking drugs sma renin and diuretics. atients into There is still no escaping the element of trial and levels). All error in treating hypertension. None the less, a ls in blood rational approach is easy to see. The four principles eems clear, are (1) to give one agent and assess its effect; (2) the patient is a higher the initial pressure the more likely it is that )lockade. more agents will be needed; (3) to choose agents in ,he sympa-ranking order of their acceptability to the patient; system has (4) to aid compliance, minimise the number of rabbits can tablets. 
